VivoSeq
Other

Trauma

0

Pipeline Programs

11

Active Trials

3

Companies Involved

Trauma is an early-stage landscape with 0 programs across 3 companies. The most active players are GSK, Sanofi, Norther Private Collage of Nursing.

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

22/100

Mech. Concentration

N/A

Completion Rate

79/100

Attrition Rate

15/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

55

clinical trials

Completed31 · 56%
Recruiting8 · 15%
Terminated7 · 13%
Unknown status5 · 9%
Active, not recruiting2 · 4%
Withdrawn1 · 2%
Other1 · 2%

Trial Activity

55 trials

Fibrinogen Early In Severe Trauma StudY II
Recruiting··Phase 3·NCT05449834·900 enrolled
Humacyte Human Acellular Vessel (HAV) in Patients With Vascular Trauma
Active, not recruiting·HHumacyte, Inc.·Phase 2/3·NCT03005418·72 enrolled
Identity Oriented Psychotrauma Therapy on Hashimoto in Adults
Completed··N/A·NCT04600349·70 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)